Strategies to counter MDR include ABC transporter inhibitors, alternative therapeutics that bypass efflux mechanisms, and gene silencing techniques to restore drug sensitivity in resistant cancer cells (Modi et al., 2022). Here, ABCG2 is linked to cancer.